Insider purchase at Albireo Pharma (ALBO) comes in face of Selling Trend of Last 90 Days

Thursday, January 25, 2018 10:15 PM ET

Insider purchase at Albireo Pharma (ALBO) comes in face of Selling Trend of Last 90 Days

One insider — PERCEPTIVE ADVISORS LLC, 10% Owner — today, bought 275,000 shares of Albireo Pharma having a market value of approximately $9,075,000, as revealed in a form 4 document filed with the SEC. There was one insider buy/sell transaction in the past 90 days prior to this transaction which resulted in the sale of 500,000 shares. Adding the most recent activity to this 90-day history indicates insider trades have been net sales of 225,000 shares and have averaged 387,500 shares per transaction over this time period.

Relative to its peers over the last 90 days, insider buy/sell trading at Albireo Pharma is higher than the 280-company peer group average. Bio Therapeutic Drugs peer group saw 337 buy/sell trades during this period for an average of 1.2 transactions per company. The number of shares per buy/sell trade for Albireo Pharma insiders was also higher. Within the peer group there were 48,869,513 shares purchased and 42,396,279 shares sold with company insiders having bought 29,558 shares on average.

The data obtained in evaluating and writing in this story eliminates all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers.

Using proprietary Natural Language Generation (NLG) technology, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.

For more information, contact UpTick at info@uptickdata.com. Copyright 2018 UpTick Data Technologies. All rights reserved.

This entry was posted in InsiderNews and tagged , , , , . Bookmark the permalink.